Arq. Bras. Cardiol. 2018; 111(6): 822-823
Can Non-Pharmacological Treatment Promote Additional Benefit for Children with Familial Hypercholesterolemia Treated with Statins?
DOI: 10.5935/abc.20180235
This Short Editorial is referred by the Research article "Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis".
Familial hypercholesterolemia (FH) is described as an autosomal dominant hereditary disease characterized by elevation of total cholesterol and low density lipoprotein (LDL-c).
FH is considered a major modifiable risk factor for the development of atherosclerosis and cardiovascular disease (CVD). The early institution of lipid-lowering therapy and its lifelong maintenance are important aspects in the prevention of premature CVD and the risk of death in this population, increasing life expectancy in these patients.
[…]
Can Non-Pharmacological Treatment Promote Additional Benefit for
Children with Familial Hypercholesterolemia Treated with
Statins?
323